Auryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY, Manufact Supply Disruption — Akebia Therapeutics dba Keryx
Auryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY, Manufact Supply Disruption — Akebia Therapeutics dba Keryx is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Auryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY, Manufact; Manufacturer: Akebi
| Drug name | Auryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY, Manufact |
|---|---|
| Manufacturer | Akebia Therapeutics dba Keryx Biopharmaceutials, Inc |
| Recall/Disruption reason | Failed Dissolution Specifications |
| Risk classification | Low Risk — Unlikely to Cause Adverse Health Effects |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-0260-2021 |
| Initiation date | 20210129 |
| Quantity affected | 17,664 bottles |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →